Evaluation of Marginal Bone Loss (MBL) 12 Months Post-loading of Implants Supporting Individual Crowns, Based on the Height of the Intermediate Abutment and Its Placement Time. Immediate Abutments of 2 or 3 Mm Show the Lowest MBL, Whereas 1.5 Mm or Delayed Abutments Are Associated with Higher MBL.
NCT ID: NCT06667531
Last Updated: 2024-10-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2022-06-15
2024-06-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Materials and Methods: 54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery1), group 2 (height 2; surgery1), group 3 (height 1.5; surgery1), group 4 (height 3; surgery2), group 5 (height 2; surgery2), group 6 (height 1.5; surgery2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant surgery, crown placement (T1), and at 3 (T2), 6 (T3), and 12 months after loading (T4). Partial and total MBL were compared among the treatment groups.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Surgical Procedures. Patients received a complete clinical (periodontal chart) and radiographic (intraoral radiographs, orthopantomography, and CBCT) examination. All surgical procedures were performed by the same surgeon (JQH) under local anesthesia (Artinibsa®; Inibsa Dental SLU, Barcelona, Spain). The implant size was selected based on digital planning with CBCT (Planmeca Romexis Software) according to the quantity and quality of bone. Prior to surgery, the thickness of the soft tissue (from the mucosal surface to the crestal bone) at the implant placement site was measured with a periodontal probe (15 mm, PCP UNC 15; HuFriedy). A conventional placement protocol was followed, with delayed installation of the implant in a fully healed socket (minimum 16 weeks of healing after tooth extraction). Osteotomy was performed without irrigation at low revolutions (100 rpm) following the defined protocol according to implant size and bone density. All implants were placed 1.5 mm subcrestally. All patients received pharmacological prescription with antibiotics (Amoxicillin 1 g every 12 hours for 7 days) or clindamycin in case of allergy, anti-inflammatory medication (Dexketoprofen 25 mg every 8 hours for 3 days), and probiotics (1 sachet per day for 1 week), in addition to postoperative care instructions: pressure with gauze for 5 minutes, application of ice for 10 minutes, soft and cold diet for the first 24 hours, and rinses with 0.12% chlorhexidine (Perioaid; Dentaid SL; Cerdanyola, Spain) twice a day for 7 days. Sutures were removed after 7 days.
* Restorative Procedures. Eight weeks after the implant installation surgery, the platforms of the submerged implants were exposed and the intermediate abutment was connected with a torque of 35 Ncm. Ten weeks after surgery and after increasing the intermediate abutment torque to 35 Ncm on the non-submerged implants, the prosthetic phase began for all cases. All definitive implant-supported prostheses were unitary screw-retained metal-ceramic crowns. Records for the laboratory were obtained in all cases through digital intraoral scanning (iTero®; Align Technology Inc; San José; California, USA). The CAD design of the restorations was done using Exocad Software. The CAM fabrication of the restorations involved milling the metal framework and layering the ceramic covering on a printed model. The unitary crowns were screwed in 2 weeks after the scanning phase with a prosthetic screw torque of 20 Ncm (conventional loading for all cases: 12 weeks after implant placement surgery). The screw channels were sealed with Teflon and compact composite (GrandioSo; Voco GmbH; Cuxhaven, Germany). Occlusion was adjusted, and the adequacy of contact points and gingival sealing was checked.
* Radiographic Evaluation. Standardized digital intraoral radiographs with a silicone key and Rhin ring positioner (Planmeca Prox + Planmeca Prosensor HD; Planmeca Oy; Helsinki, Finland) were obtained at implant placement (baseline), at definitive crown placement (T1), and at 3 months (T2), 6 months (T3), and 12 months (T4) after functional loading. For MBL measurement, the Planmeca Romexis dental imaging software platform was used. Linear measurements were taken in each intraoral radiograph from the most mesial and distal point of the implant shoulder to the crestal bone. The magnification of the radiographs was corrected based on the radiographic measurement of the height and width of each implant, from which each linear MBL measurement was calibrated and recalculated.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
54 patients received at least one single screw-retained crown on an implant replacing a posterior tooth (60 implants). The implants were divided into six treatment groups based on the height (1.5 mm; 2 mm; 3 mm) and timing of placement (immediate: surgery 1; delayed: surgery 2) of the intermediate abutment: group 1 (height 3; surgery 1), group 2 (height 2; surgery 1), group 3 (height 1.5; surgery 1), group 4 (height 3; surgery 2), group 5 (height 2; surgery 2), group 6 (height 1.5; surgery 2). Mesial and distal linear radiographic measurements (from the implant shoulder to the bone crest) were performed at five follow-up times: implant
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (height 3; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Group 2 (height 2; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Group 3 (height 1.5; surgery 1)
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Group 4 (height 3; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Group 5 (height 2; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Group 6 (height 1.5; surgery 2)
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 3 mm.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 2 mm.
Implant
Placement of an immediate intermediate abutment (in implant placement surgery). This abutment has a height of 1.5 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 3 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 2 mm.
Implant
Placement of a delayed intermediate abutment (in the second implant surgery). This abutment has a height of 1.5 mm.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Plaque and bleeding indices below 10%.
* Absence of chronic periodontal diseases (periodontitis) or acute periodontal diseases (periodontal abscess).
* Presence of intact alveolar walls.
* Sufficient bone height and width.
* Need for restoration of a tooth in the posterior maxillary or mandibular region (premolars and molars).
* Incorporation into a periodontal maintenance program.
Exclusion Criteria
* Pregnant or breastfeeding women.
* Smokers of more than 10 cigarettes per day.
* Parafunctional habits.
* Alcohol or drug abuse.
* Narrow interproximal spaces (less than 9 mm).
* Placement of implants flapless or post-extraction.
* Insertion torque during implant placement below 35 Ncm.
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Salamanca
OTHER
Quintas Hijós Clínica Dental
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacobo Quintas Hijós
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Esteban Pérez Pevida, Dentistry
Role: STUDY_DIRECTOR
University of Salamanca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Salamanca
Salamanca, Salamanca, Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Quintas-Hijos J, Perez-Pevida E. Influence of intermediate abutment height and timing of placement on marginal bone loss in single implant-supported crowns: a 12-month follow-up randomized clinical trial. Clin Oral Investig. 2025 May 8;29(6):291. doi: 10.1007/s00784-025-06364-8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
C.I. PI22/324
Identifier Type: -
Identifier Source: org_study_id